Terms: = Brain cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43
47 results:
1. Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.
Fares J; Petrosyan E; Kanojia D; Dmello C; Cordero A; Duffy JT; Yeeravalli R; Sahani MH; Zhang P; Rashidi A; Arrieta VA; Ulasov I; Ahmed AU; Miska J; Balyasnikova IV; James CD; Sonabend AM; Heimberger AB; Lesniak MS
J Clin Invest; 2023 Dec; 133(24):. PubMed ID: 37847564
[TBL] [Abstract] [Full Text] [Related]
2. Clinical feasibility of a commercially available MRI-only method for radiotherapy treatment planning of the brain.
Ranta I; Wright P; Suilamo S; Kemppainen R; Schubert G; Kapanen M; Keyriläinen J
J Appl Clin Med Phys; 2023 Sep; 24(9):e14044. PubMed ID: 37345212
[TBL] [Abstract] [Full Text] [Related]
3. PARP3 supervises G9a-mediated repression of adhesion and hypoxia-responsive genes in glioblastoma cells.
Nguekeu-Zebaze L; Hanini N; Noll A; Wadier N; Amé JC; Roegel L; Dantzer F
Sci Rep; 2022 Sep; 12(1):15534. PubMed ID: 36109561
[TBL] [Abstract] [Full Text] [Related]
4. N-myc Downstream-Regulated Gene 1 (ndrg1) Regulates Vascular Endothelial Growth Factor A (VEGFA) and Malignancies in Glioblastoma Multiforme (GBM).
Zhang X; Chen Q; Li Y; Chen H; Jiang Q; Hu Q
Biomed Res Int; 2022; 2022():3233004. PubMed ID: 35813230
[TBL] [Abstract] [Full Text] [Related]
5. Targeting radiation-tolerant persister cells as a strategy for inhibiting radioresistance and recurrence in glioblastoma.
Gu J; Mu N; Jia B; Guo Q; Pan L; Zhu M; Zhang W; Zhang K; Li W; Li M; Wei L; Xue X; Zhang Y; Zhang W
Neuro Oncol; 2022 Jul; 24(7):1056-1070. PubMed ID: 34905060
[TBL] [Abstract] [Full Text] [Related]
6. ndrg1 in Aggressive Breast cancer Progression and brain Metastasis.
Villodre ES; Hu X; Eckhardt BL; Larson R; Huo L; Yoon EC; Gong Y; Song J; Liu S; Ueno NT; Krishnamurthy S; Pusch S; Tripathy D; Woodward WA; Debeb BG
J Natl Cancer Inst; 2022 Apr; 114(4):579-591. PubMed ID: 34893874
[TBL] [Abstract] [Full Text] [Related]
7. Design of a 3D patient-specific collision avoidance virtual framework for half-gantry proton therapy system.
Dougherty JM; Whitaker TJ; Mundy DW; Tryggestad EJ; Beltran CJ
J Appl Clin Med Phys; 2022 Feb; 23(2):e13496. PubMed ID: 34890094
[TBL] [Abstract] [Full Text] [Related]
8. The Influence of ndrg1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population.
Yang Y; Cheng Y; Yang L; Shi G; Chen P; Li L; Fang H; Chen C; Jin T
Cell Mol Neurobiol; 2022 Aug; 42(6):1949-1964. PubMed ID: 33709284
[TBL] [Abstract] [Full Text] [Related]
9. Identification and Characterization of cancer Cells That Initiate Metastases to the brain and Other Organs.
Berghoff AS; Liao Y; Karreman MA; Ilhan-Mutlu A; Gunkel K; Sprick MR; Eisen C; Kessler T; Osswald M; Wünsche S; Feinauer M; Gril B; Marmé F; Michel LL; Bago-Horvath Z; Sahm F; Becker N; Breckwoldt MO; Solecki G; Gömmel M; Huang L; Rübmann P; Thome CM; Ratliff M; Trumpp A; Steeg PS; Preusser M; Wick W; Winkler F
Mol Cancer Res; 2021 Apr; 19(4):688-701. PubMed ID: 33443114
[TBL] [Abstract] [Full Text] [Related]
10. Bidirectional Regulation between ndrg1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract] [Full Text] [Related]
11. A method for cranial target delineation in radiotherapy treatment planning aided by single-voxel magnetic resonance spectroscopy: evaluation using a custom-designed gel-based phantom and simulations.
Zeinali-Rafsanjani B; Mosleh-Shirazi MA; Faghihi R; Saeedi-Moghadam M; Lotfi M; Jalli R
Br J Radiol; 2019 Dec; 92(1104):20190216. PubMed ID: 31556332
[TBL] [Abstract] [Full Text] [Related]
12. Nervous NDRGs: the N-myc downstream-regulated gene family in the central and peripheral nervous system.
Schonkeren SL; Massen M; van der Horst R; Koch A; Vaes N; Melotte V
Neurogenetics; 2019 Oct; 20(4):173-186. PubMed ID: 31485792
[TBL] [Abstract] [Full Text] [Related]
13. Discovery of a novel rhein-SAHA hybrid as a multi-targeted anti-glioblastoma drug.
Chen J; Luo B; Wen S; Pi R
Invest New Drugs; 2020 Jun; 38(3):755-764. PubMed ID: 31414267
[TBL] [Abstract] [Full Text] [Related]
14. Tissue segmentation-based electron density mapping for MR-only radiotherapy treatment planning of brain using conventional T1-weighted MR images.
Yu H; Oliver M; Leszczynski K; Lee Y; Karam I; Sahgal A
J Appl Clin Med Phys; 2019 Aug; 20(8):11-20. PubMed ID: 31257709
[TBL] [Abstract] [Full Text] [Related]
15. Zero TE-based pseudo-CT image conversion in the head and its application in PET/MR attenuation correction and MR-guided radiation therapy planning.
Wiesinger F; Bylund M; Yang J; Kaushik S; Shanbhag D; Ahn S; Jonsson JH; Lundman JA; Hope T; Nyholm T; Larson P; Cozzini C
Magn Reson Med; 2018 Oct; 80(4):1440-1451. PubMed ID: 29457287
[TBL] [Abstract] [Full Text] [Related]
16. Systematic Review of Synthetic Computed Tomography Generation Methodologies for Use in Magnetic Resonance Imaging-Only Radiation Therapy.
Johnstone E; Wyatt JJ; Henry AM; Short SC; Sebag-Montefiore D; Murray L; Kelly CG; McCallum HM; Speight R
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):199-217. PubMed ID: 29254773
[TBL] [Abstract] [Full Text] [Related]
17. Time- and oxygen-dependent expression and regulation of ndrg1 in human brain cancer cells.
Said HM; Safari R; Al-Kafaji G; Ernestus RI; Löhr M; Katzer A; Flentje M; Hagemann C
Oncol Rep; 2017 Jun; 37(6):3625-3634. PubMed ID: 28498432
[TBL] [Abstract] [Full Text] [Related]
18. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract] [Full Text] [Related]
19. Technical feasibility of integrating 7 T anatomical MRI in image-guided radiotherapy of glioblastoma: a preparatory study.
Compter I; Peerlings J; Eekers DB; Postma AA; Ivanov D; Wiggins CJ; Kubben P; Küsters B; Wesseling P; Ackermans L; Schijns OE; Lambin P; Hoffmann AL
MAGMA; 2016 Jun; 29(3):591-603. PubMed ID: 27026245
[TBL] [Abstract] [Full Text] [Related]
20. ndrg1 overexpressing gliomas are characterized by reduced tumor vascularization and resistance to antiangiogenic treatment.
Broggini T; Wüstner M; Harms C; Stange L; Blaes J; Thomé C; Harms U; Mueller S; Weiler M; Wick W; Vajkoczy P; Czabanka M
Cancer Lett; 2016 Oct; 380(2):568-576. PubMed ID: 26297987
[TBL] [Abstract] [Full Text] [Related]
[Next]
